ClinicalTrials.Veeva

Menu

Motivation for Exercise and Physical Activity Adherence (MOVE)

University of Colorado Denver (CU Denver) logo

University of Colorado Denver (CU Denver)

Status

Completed

Conditions

Obesity

Treatments

Behavioral: MOVE

Study type

Observational

Funder types

Other
NIH

Identifiers

NCT04937205
19-0826
F32DK122652 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

The limited success of our current approaches to increase adoption and maintenance of physical activity in adults with overweight and obesity is a substantial barrier to effectively address the current obesity epidemic. This mentored F32 application addresses the significant public health issue of obesity and associated risk of major chronic diseases by using mixed methods research to optimize an innovative, theoretically based physical activity intervention designed to enhance motivation for exercise in adults with overweight and obesity.

Full description

Physical activity (PA) is one of the best predictors of sustained weight loss and current guidelines recommend high levels of PA to prevent weight regain after weight loss. However, long-term adherence to PA is generally poor when adults with overweight/obesity are provided an exercise prescription consistent with current guidelines. Thus, it is essential to evaluate novel strategies to enhance adoption and maintenance of PA in adults with overweight/obesity. The overall goal of this mentored F32 application is to use mixed methods research to optimize an innovative, theoretically based PA intervention designed to enhance motivation for exercise in adults with overweight/obesity. Specifically, the objectives of this proposal are to evaluate and optimize a theory-based PA intervention (called MOVE) designed to enhance motivation for exercise as a sub-study of an ongoing weight loss "parent" trial (COMIRB, Protocol #17-0369). In Aim 1, adults from an ongoing behavioral weight loss trial (R01DK111622) will receive the MOVE intervention and participate in focus groups to explore how participants experience MOVE. In Aim 2, we will use a mixed methods convergent design to integrate quantitative results from a secondary data analysis and qualitative results (Aim 1) to optimize MOVE in preparation for a full evaluation of MOVE in a future randomized controlled study.

Enrollment

39 patients

Sex

All

Ages

18 to 60 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • A current study participant randomized to the parent trial in cohorts 2-4 for COMIRB, Protocol #17-0369
  • Completed at least 2 of 3 MOVE program components (attended ≥80% of either group-based class and/or attended the one-on-one support session).

Exclusion criteria

  • None

Trial design

39 participants in 3 patient groups

Cohort 2
Description:
This group of study participants started the 52-week parent randomized controlled trial (NCT03411356) on February 13, 2019.
Treatment:
Behavioral: MOVE
Cohort 3
Description:
This group of study participants started the 52-week parent randomized controlled trial (NCT03411356) on November 5, 2019.
Treatment:
Behavioral: MOVE
Cohort 4
Description:
This group of study participants started the 52-week parent randomized controlled trial (NCT03411356) on October 22, 2020.
Treatment:
Behavioral: MOVE

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems